IL6 and COVID-19: Altogether, these findings open a new strategy therapy for COVID-19.Adjuvant immune therapy for COVID-19 has usually been focused on blockinghyperinflammation (e.g., corticosteroids, IL-6 inhibitors, JAK inhibitors), asrecommended by WHO guidelines (29).